z-logo
open-access-imgOpen Access
Single dose of propofol causing propofol infusion syndrome in a newborn
Author(s) -
Carolina Michel-Macías,
Deneb Algedi Morales-Barquet,
A M Reyes-Palomino,
J A Machuca-Vaca,
Alejandra Orozco-Guillén
Publication year - 2018
Publication title -
oxford medical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.169
H-Index - 9
ISSN - 2053-8855
DOI - 10.1093/omcr/omy023
Subject(s) - medicine , propofol , rhabdomyolysis , metabolic acidosis , anesthesia , bolus (digestion) , acidosis , surgery
Propofol infusion syndrome (PRIS) is a rare syndrome originally described in critically ill children undergoing long-term (> 48 h) propofol infusion at high doses (> 4 mg/kg/h). Severe metabolic acidosis, rhabdomyolysis, renal failure and fatal cardiac failure are the features. Herein, we present a case of a newborn who developed PRIS after a single bolus dose of propofol at 3.2 mg/kg/do, developing rhabdomyolysis and severe metabolic acidosis, with a successful outcome after medical therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom